Sharechat Logo

Orion flags further US contract delays; stock drops 5% to record low

Wednesday 10th June 2015

Text too small?

Orion Health, the healthcare system software developer which listed on the NZX last November, says an expected US based contract has been delayed. Its shares sank to a record low.

The Auckland based company said a contract with one of its US payer customers has been delayed for 12 months because the customer wants "to focus on more immediate priorities", but Orion didn't see the need to revise its forecasts for 2016. Orion flagged two contracts with US payers in the lead up to its initial public offer last year, and has since engaged with other US companies, and is expecting to complete contracts by the end of its first half in September. 

The healthcare management system company said significant opportunities had arisen in other market sectors which were in "major adjacent market areas such as pharmaceuticals and chronic care management". 

Orion stock is the third worst performer on the benchmark NZX 50 Index this year. The company said on Jan. 30 that delays in settling contracts and paying bills in North America would weigh on revenue in the second half of its financial year. North American sales were also dented as it moved customers to subscription contracts from perpetual licences, it said.

The Orion share price fell 5.2 percent in early trading on the NZX to a record low of $4.20, having sold in its initial public offering at $5.70 and stagged on listing to $6.27. 

The company joined the NZX on Nov. 26 in a $125 million capital raising to assist the 22 year old company to grow in global markets. Its offer documents gave no prospective forward financial information, and the company told investors that was because "recurring revenues currently represent less than one third of operating revenue and there is inherent uncertainty around the capture of customer contracts and the timing of their execution, and recognition of the associated revenues."

It reported an annual loss of $60.8 million in the year ended March 31, from a loss of $1.1 million a year earlier, in line with its strategy to grow revenues before becoming profitable. The company's annual revenues rose 7 percent to $164.1 million.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

AGL - Change in Senior Management
Devon Funds Morning Note - 01 May 2024
Rick Christie to step-aside as a non-executive director
CHI - New customer contract to upgrade Marsden Point
Synlait announces changes to Board of Directors
May 1st Morning Report
Devon Funds Morning Note - 30 April 2024
New Rural Advocacy Hub to be launched at Fieldays 2024
Serko signs five-year partnership renewal with Booking.com
NPH - 2024 Half Year Results Announcement Date